Very Early Surfactant Without Mandatory Ventilation in Premature Infants Treated With Early Continuous Positive Airway Pressure: A Randomized, Controlled Trial
about
Continuous distending pressure for respiratory distress in preterm infantsProphylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infantsEarly versus delayed selective surfactant treatment for neonatal respiratory distress syndromeContinuous positive airway pressure in preterm neonates: an update of current evidence and implications for developing countriesDo practicing clinicians agree with expert ratings of neonatal intensive care unit quality measures?Early surfactant therapy with nasal continuous positive airway pressure or continued mechanical ventilation in very low birth weight neonates with respiratory distress syndromeEarly prophylactic versus late selective use of surfactant for respiratory distress syndrome in very preterm infants: a collaborative study of 53 multi-center trials in Korea.Effects of daily kangaroo care on cardiorespiratory parameters in preterm infants.A comparison of surfactant administration through i-gel and ET-tube in the treatment of respiratory distress syndrome in newborns weighing more than 2000 gramsImplementation methods for delivery room management: a quality improvement comparison study.The OPTIMIST-A trial: evaluation of minimally-invasive surfactant therapy in preterm infants 25-28 weeks gestation.Exogenous surfactant therapy in 2013: what is next? Who, when and how should we treat newborn infants in the future?Targeting inflammation to prevent bronchopulmonary dysplasia: can new insights be translated into therapies?Initial Treatment of Respiratory Distress Syndrome with Nasal Intermittent Mandatory Ventilation versus Nasal Continuous Positive Airway Pressure: A Randomized Controlled Trial.Impact of the systematic introduction of low-cost bubble nasal CPAP in a NICU of a developing country: a prospective pre- and post-intervention studyThe new bronchopulmonary dysplasia.The importance of administration of early surfactant and nasal continuous positive airway pressure in newborns with respiratory distress syndrome.Regional variation on rates of bronchopulmonary dysplasia and associated risk factorsEvaluation of a practice guideline for the management of respiratory distress syndrome in preterm infants: A quality improvement initiativeAnalysis and comparison of the effects of N-BiPAP and Bubble-CPAP in treatment of preterm newborns with the weight of below 1500 grams affiliated with respiratory distress syndrome: A randomised clinical trial.Efficacy and safety of surfactant replacement therapy for preterm neonates with respiratory distress syndrome in low- and middle-income countries: a systematic review.Comparison of the Efficacy of Three Natural Surfactants (Curosurf, Survanta, and Alveofact) in the Treatment of Respiratory Distress Syndrome Among Neonates: A Randomized Controlled Trial.Surfactant in the preterm infant: what's going on.Pilot observational study on haemodynamic changes after surfactant administration in preterm newborns with respiratory distress syndrome.Old and new uses of surfactant.RDS--CPAP or surfactant or both.ELBW infants: to intubate or not to intubate in the delivery room?Surfactant therapy for neonatal respiratory distress syndrome in 2013.Use of CPAP and surfactant therapy in newborns with respiratory distress syndrome.Efficacy and safety of bubble CPAP in neonatal care in low and middle income countries: a systematic review.The role of surfactant and non-invasive mechanical ventilation in early management of respiratory distress syndrome in premature infants.Nasal continuous positive airway pressure versus nasal intermittent positive-pressure ventilation within the minimally invasive surfactant therapy approach in preterm infants: a randomised controlled trial.A Comparison of the Effect of Nasal bi-level Positive Airway Pressure and Sigh-positive Airway Pressure on the Treatment of the Preterm Newborns Weighing Less than 1500 g Affiliated with Respiratory Distress Syndrome.Evolution of surfactant therapy for respiratory distress syndrome: past, present, and future.Efficacy and safety of CPAP in low- and middle-income countries.Golden 60 minutes of newborn's life: Part 1: Preterm neonate.Surfactant for Respiratory Distress Syndrome: New Ideas on a Familiar Drug with Innovative Applications.Golden hour of neonatal life: Need of the hour.A comparison of two interventions for HHHFNC in preterm infants weighing 1,000 to 1,500 g in the recovery period of newborn RDS.Flow-synchronized nasal intermittent positive pressure ventilation for infants <32 weeks' gestation with respiratory distress syndrome.
P2860
Q24186567-A72EF171-0806-4F57-85FA-18AFFE4053F5Q24201075-05BC2C27-DA0C-452A-AE8A-78C01240F63FQ24202890-BDA356A3-1131-477F-9BB6-0D8A190D4D22Q28084570-54443524-0F3A-4E33-AD0F-44BD9B0BBA4FQ30414217-59CE4077-2D18-4342-AD3F-4D182C527652Q33640615-C31DD24E-13BB-4ABC-BACB-7F80548684C4Q34030003-D98E9191-E7A9-4497-9E55-EAB9544E7EC8Q34103590-4C229F89-D03A-4366-90AA-13CAD197A5E8Q34170202-0B666E07-EC5C-4AAB-B6D5-786251208562Q34411226-4AE76AAE-E8F9-458F-B42B-0B768683A00FQ34538793-EBE4F3E7-74C1-4923-AA4E-6E422F77035AQ35013615-58747D6D-175D-4EDD-8CAA-094B4D1D807FQ35070866-24C86922-C52E-4EA1-9518-8A607A84F42DQ35109336-83E31CE2-080C-48B1-AAFD-970217A66982Q35222972-88E9E9C5-69FA-41E4-B002-0A5418569914Q35693783-C9301094-56FA-458B-8E96-3EAC8A49DECCQ35712758-87806C49-A98C-4A9B-8B02-BD1ECCA8F0BCQ36102174-3BB48030-B1A5-44AB-814F-4D980E0C3ABAQ36592927-E28B2734-A47D-4BA5-892C-2B7B43B292E2Q36606883-48F72667-084C-405A-B8DA-66BD5D5D2974Q36846504-CB9A52D7-8043-45BE-9B44-27FCFA87141CQ37631249-A089FD15-3123-4D69-9086-08F31063E985Q37635168-27F845C0-2C03-44AC-A057-4E79145AE583Q37699773-C3189D52-980D-4169-9803-E1AF21FDB179Q37788261-915408DD-9471-4F15-9A76-4FEB1AB85C92Q37992221-53D86DAC-ACC9-4105-897B-B6480FB169B8Q38041602-66DC2181-B513-4D81-9646-5C42B8B0CC6EQ38141083-B7B07FE4-135A-4300-8DE6-101E48B77517Q38203803-FFBE81BC-8D42-4282-B4D7-6568F8991AD6Q38236219-6537F6F3-70FC-4FD2-8E82-44613FC92A4BQ38240057-14E59596-7B79-4FD2-8CA0-F6DF21BE2168Q38400442-55C2395F-F0C7-4D48-98DB-F9B94655F79DQ38497735-CA96E0F5-8528-4FB7-9801-053A8B491C15Q38814650-E536B1B8-45AF-445F-9A8C-4EE040387346Q38816134-FF9047DA-E642-4906-82FD-B8FD6CEC834CQ39008948-ECF2C616-2B7A-45ED-A21D-85B6A70A047EQ41054291-A57E444E-3D8F-4503-B5E8-A0BEB7C6D50CQ41716215-513635EE-F3E0-4266-B28D-CD65FBC9EC88Q41809713-597B0EAD-8DED-405F-9A01-82FD51B5B4A1Q42115028-20B8ADA7-F6F3-468F-9C1D-DB7F4EED1431
P2860
Very Early Surfactant Without Mandatory Ventilation in Premature Infants Treated With Early Continuous Positive Airway Pressure: A Randomized, Controlled Trial
description
im Januar 2009 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 2009
@uk
name
Very Early Surfactant Without ...... A Randomized, Controlled Trial
@en
Very Early Surfactant Without ...... A Randomized, Controlled Trial
@nl
type
label
Very Early Surfactant Without ...... A Randomized, Controlled Trial
@en
Very Early Surfactant Without ...... A Randomized, Controlled Trial
@nl
prefLabel
Very Early Surfactant Without ...... A Randomized, Controlled Trial
@en
Very Early Surfactant Without ...... A Randomized, Controlled Trial
@nl
P2093
P356
P1433
P1476
Very Early Surfactant Without ...... A Randomized, Controlled Trial
@en
P2093
C. L. Bose
J. A. Bastidas
J. Garcia-Harker
J. M. Lozano
L. A. Celis
L. A. Perez
M. A. Rojas
M. A. Rondon
P304
P356
10.1542/PEDS.2007-3501
P407
P577
2009-01-01T00:00:00Z